RESUMO
Patients with heart disease, or at high risk of developing a cardiac condition, usually undergo risk assessment by primary care physicians, internal medicine doctors, or cardiologists. There are several methods that can be used for this risk assessment, and their applicability differs with respect to availability, complexity, and usefulness in different geographic populations. This document focuses on some of the many relevant clinical topics recently presented in the "Expert Consensus on Risk Assessment in Cardiac Arrhythmias: Use the Right Tool for the Right Outcome," which include statements based on the best available evidence. In this review, we want to highlight and make some pertinent comments on some of the most relevant points of this Consensus.
Assuntos
Cardiopatias , Taquicardia Ventricular , Arritmias Cardíacas/diagnóstico , Consenso , Humanos , Medição de RiscoRESUMO
Cardiac arrhythmias in pregnant women are a common entity and often drug-refractory. The major concern about using radiofrequency (RF) catheter ablation guided by fluoroscopy to treat arrhythmias during pregnancy is the potential consequences of exposing the fetus to radiation. We present two pregnant patients with incessant and life-threatening supraventricular tachycardias successfully treated by conventional RF ablation under strict radioactive dosimeter surveillance. The availability of better fluoroscopy and lead shielding techniques allows to perform RF ablation of drug-refractory and poorly tolerated supraventricular arrhythmias at any stage of pregnancy, with an appropriate tracking of the radiation dose received by both mother and fetus.